Authors: Col, NF Hirota, LK Orr, RK Erban, JK Wong, JB Lau, J

Citation: Nf. Col et al., Hormone replacement therapy after breast cancer: A systematic review and quantitative assessment of risk, J CL ONCOL, 19(8), 2001, pp. 2357-2363

Authors: Pandya, KJ Yeap, BY Weiner, LM Krook, JE Erban, JK Schinella, RA Davis, TE

Citation: Kj. Pandya et al., Megestrol and tamoxifen in patients with advanced endometrial cancer - An Eastern Cooperative Oncology Group study (E4882), AM J CL ONC, 24(1), 2001, pp. 43-46

Authors: Narayanasami, U Kanteti, R Morelli, J Klekar, A Al-Olama, A Keating, C O'Connor, C Berkman, E Erban, JK Sprague, KA Miller, KB Schenkein, DP

Citation: U. Narayanasami et al., Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation, BLOOD, 98(7), 2001, pp. 2059-2064

Authors: Stadtmauer, EA O'Neill, A Goldstein, LJ Crilley, PA Mangan, KF Ingle, JN Brodsky, I Martino, S Lazarus, HM Erban, JK Sickles, C Glick, JH

Citation: Ea. Stadtmauer et al., Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer., N ENG J MED, 342(15), 2000, pp. 1069-1076